Does IXEKIZUMAB Cause Ankylosing spondylitis? 82 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Ankylosing spondylitis have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.2% of all adverse event reports for IXEKIZUMAB.
82
Reports of Ankylosing spondylitis with IXEKIZUMAB
0.2%
of all IXEKIZUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Ankylosing spondylitis From IXEKIZUMAB?
Of the 82 reports, 4 (4.9%) required hospitalization.
Is Ankylosing spondylitis Listed in the Official Label?
Yes, Ankylosing spondylitis is listed as a known adverse reaction in the official FDA drug label for IXEKIZUMAB.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Ankylosing spondylitis?
CERTOLIZUMAB PEGOL (2,580)
ADALIMUMAB (2,378)
SECUKINUMAB (1,942)
ETANERCEPT (1,456)
METHOTREXATE (1,067)
DICLOFENAC (874)
INFLIXIMAB (789)
GOLIMUMAB (643)
LEFLUNOMIDE (413)
CELECOXIB (329)
Which IXEKIZUMAB Alternatives Have Lower Ankylosing spondylitis Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID